nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—SLC15A2—multiple sclerosis	0.699	1	CbGaD
Cilazapril—ABCB1—Methylprednisolone—multiple sclerosis	0.0348	0.232	CbGbCtD
Cilazapril—ABCB1—Mitoxantrone—multiple sclerosis	0.0254	0.169	CbGbCtD
Cilazapril—ABCB1—Betamethasone—multiple sclerosis	0.0227	0.151	CbGbCtD
Cilazapril—ABCB1—Prednisolone—multiple sclerosis	0.0224	0.149	CbGbCtD
Cilazapril—ABCB1—Prednisone—multiple sclerosis	0.0211	0.141	CbGbCtD
Cilazapril—ABCB1—Dexamethasone—multiple sclerosis	0.0132	0.0878	CbGbCtD
Cilazapril—ABCB1—Methotrexate—multiple sclerosis	0.0106	0.0705	CbGbCtD
Cilazapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00343	0.424	CbGpPWpGaD
Cilazapril—Fosinopril—SLC15A2—multiple sclerosis	0.000988	0.136	CrCbGaD
Cilazapril—Perindopril—SLC15A2—multiple sclerosis	0.000806	0.111	CrCbGaD
Cilazapril—Spirapril—SLC15A2—multiple sclerosis	0.000797	0.11	CrCbGaD
Cilazapril—Moexipril—SLC15A2—multiple sclerosis	0.000764	0.105	CrCbGaD
Cilazapril—Quinapril—SLC15A2—multiple sclerosis	0.00071	0.0976	CrCbGaD
Cilazapril—Ramipril—SLC15A2—multiple sclerosis	0.000688	0.0946	CrCbGaD
Cilazapril—Trandolapril—SLC15A2—multiple sclerosis	0.000688	0.0946	CrCbGaD
Cilazapril—Benazepril—SLC15A2—multiple sclerosis	0.000618	0.0849	CrCbGaD
Cilazapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000462	0.0571	CbGpPWpGaD
Cilazapril—Perindopril—BCHE—multiple sclerosis	0.000422	0.0581	CrCbGaD
Cilazapril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.000389	0.0481	CbGpPWpGaD
Cilazapril—Ramipril—BCHE—multiple sclerosis	0.000361	0.0496	CrCbGaD
Cilazapril—Nateglinide—SLC15A2—multiple sclerosis	0.000356	0.0489	CrCbGaD
Cilazapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000272	0.0336	CbGpPWpGaD
Cilazapril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.000224	0.0277	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000208	0.0257	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000194	0.0241	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000194	0.0241	CbGpPWpGaD
Cilazapril—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000136	0.00102	CcSEcCtD
Cilazapril—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000136	0.00102	CcSEcCtD
Cilazapril—Discomfort—Triamcinolone—multiple sclerosis	0.000136	0.00101	CcSEcCtD
Cilazapril—Discomfort—Methylprednisolone—multiple sclerosis	0.000136	0.00101	CcSEcCtD
Cilazapril—Headache—Azathioprine—multiple sclerosis	0.000136	0.00101	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000136	0.00101	CcSEcCtD
Cilazapril—Dry mouth—Triamcinolone—multiple sclerosis	0.000135	0.001	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—multiple sclerosis	0.000135	0.001	CcSEcCtD
Cilazapril—Angioedema—Dexamethasone—multiple sclerosis	0.000134	0.001	CcSEcCtD
Cilazapril—Angioedema—Betamethasone—multiple sclerosis	0.000134	0.001	CcSEcCtD
Cilazapril—Angiopathy—Prednisone—multiple sclerosis	0.000133	0.000993	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—multiple sclerosis	0.000133	0.000991	CcSEcCtD
Cilazapril—Confusional state—Methylprednisolone—multiple sclerosis	0.000133	0.00099	CcSEcCtD
Cilazapril—Immune system disorder—Prednisone—multiple sclerosis	0.000133	0.000989	CcSEcCtD
Cilazapril—Malaise—Dexamethasone—multiple sclerosis	0.000133	0.000987	CcSEcCtD
Cilazapril—Malaise—Betamethasone—multiple sclerosis	0.000133	0.000987	CcSEcCtD
Cilazapril—Oedema—Triamcinolone—multiple sclerosis	0.000132	0.000984	CcSEcCtD
Cilazapril—Vertigo—Dexamethasone—multiple sclerosis	0.000132	0.000983	CcSEcCtD
Cilazapril—Vertigo—Betamethasone—multiple sclerosis	0.000132	0.000983	CcSEcCtD
Cilazapril—Syncope—Dexamethasone—multiple sclerosis	0.000132	0.000981	CcSEcCtD
Cilazapril—Syncope—Betamethasone—multiple sclerosis	0.000132	0.000981	CcSEcCtD
Cilazapril—Arrhythmia—Prednisone—multiple sclerosis	0.000131	0.000978	CcSEcCtD
Cilazapril—Shock—Triamcinolone—multiple sclerosis	0.00013	0.000968	CcSEcCtD
Cilazapril—Insomnia—Prednisolone—multiple sclerosis	0.00013	0.000968	CcSEcCtD
Cilazapril—Alopecia—Prednisone—multiple sclerosis	0.00013	0.000967	CcSEcCtD
Cilazapril—Shock—Methylprednisolone—multiple sclerosis	0.00013	0.000966	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00013	0.000964	CcSEcCtD
Cilazapril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000129	0.000962	CcSEcCtD
Cilazapril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000129	0.000962	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—multiple sclerosis	0.000129	0.000961	CcSEcCtD
Cilazapril—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000129	0.000961	CcSEcCtD
Cilazapril—Paraesthesia—Prednisolone—multiple sclerosis	0.000129	0.000961	CcSEcCtD
Cilazapril—Tachycardia—Triamcinolone—multiple sclerosis	0.000129	0.000961	CcSEcCtD
Cilazapril—Nausea—Azathioprine—multiple sclerosis	0.000129	0.000959	CcSEcCtD
Cilazapril—Tachycardia—Methylprednisolone—multiple sclerosis	0.000129	0.000958	CcSEcCtD
Cilazapril—ACE—peripheral nervous system—multiple sclerosis	0.000129	0.225	CbGeAlD
Cilazapril—Skin disorder—Methylprednisolone—multiple sclerosis	0.000128	0.000954	CcSEcCtD
Cilazapril—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000128	0.000952	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—multiple sclerosis	0.000128	0.000951	CcSEcCtD
Cilazapril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000128	0.000949	CcSEcCtD
Cilazapril—Hypertension—Dexamethasone—multiple sclerosis	0.000127	0.000945	CcSEcCtD
Cilazapril—Hypertension—Betamethasone—multiple sclerosis	0.000127	0.000945	CcSEcCtD
Cilazapril—Asthenia—Mitoxantrone—multiple sclerosis	0.000126	0.000936	CcSEcCtD
Cilazapril—Myalgia—Dexamethasone—multiple sclerosis	0.000125	0.000932	CcSEcCtD
Cilazapril—Myalgia—Betamethasone—multiple sclerosis	0.000125	0.000932	CcSEcCtD
Cilazapril—Anxiety—Dexamethasone—multiple sclerosis	0.000125	0.000928	CcSEcCtD
Cilazapril—Anxiety—Betamethasone—multiple sclerosis	0.000125	0.000928	CcSEcCtD
Cilazapril—Discomfort—Dexamethasone—multiple sclerosis	0.000124	0.00092	CcSEcCtD
Cilazapril—Discomfort—Betamethasone—multiple sclerosis	0.000124	0.00092	CcSEcCtD
Cilazapril—Hypotension—Methylprednisolone—multiple sclerosis	0.000123	0.000918	CcSEcCtD
Cilazapril—Pain—Prednisolone—multiple sclerosis	0.000123	0.000915	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—multiple sclerosis	0.000122	0.000908	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000121	0.015	CbGpPWpGaD
Cilazapril—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000121	0.000904	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—multiple sclerosis	0.000121	0.000897	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000121	0.000897	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00012	0.000895	CcSEcCtD
Cilazapril—Oedema—Dexamethasone—multiple sclerosis	0.00012	0.000893	CcSEcCtD
Cilazapril—Oedema—Betamethasone—multiple sclerosis	0.00012	0.000893	CcSEcCtD
Cilazapril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00012	0.000893	CcSEcCtD
Cilazapril—Insomnia—Triamcinolone—multiple sclerosis	0.00012	0.00089	CcSEcCtD
Cilazapril—Insomnia—Methylprednisolone—multiple sclerosis	0.000119	0.000888	CcSEcCtD
Cilazapril—Ill-defined disorder—Prednisone—multiple sclerosis	0.000119	0.000884	CcSEcCtD
Cilazapril—Paraesthesia—Triamcinolone—multiple sclerosis	0.000119	0.000884	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisolone—multiple sclerosis	0.000119	0.000882	CcSEcCtD
Cilazapril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000119	0.000882	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—multiple sclerosis	0.000119	0.000882	CcSEcCtD
Cilazapril—Anaemia—Prednisone—multiple sclerosis	0.000118	0.000881	CcSEcCtD
Cilazapril—Shock—Betamethasone—multiple sclerosis	0.000118	0.000879	CcSEcCtD
Cilazapril—Shock—Dexamethasone—multiple sclerosis	0.000118	0.000879	CcSEcCtD
Cilazapril—Dyspnoea—Triamcinolone—multiple sclerosis	0.000118	0.000878	CcSEcCtD
Cilazapril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000118	0.000874	CcSEcCtD
Cilazapril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000118	0.000874	CcSEcCtD
Cilazapril—Tachycardia—Betamethasone—multiple sclerosis	0.000117	0.000872	CcSEcCtD
Cilazapril—Tachycardia—Dexamethasone—multiple sclerosis	0.000117	0.000872	CcSEcCtD
Cilazapril—Angioedema—Prednisone—multiple sclerosis	0.000117	0.000871	CcSEcCtD
Cilazapril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000116	0.000866	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000116	0.000865	CcSEcCtD
Cilazapril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000116	0.000864	CcSEcCtD
Cilazapril—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000116	0.000863	CcSEcCtD
Cilazapril—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000116	0.000863	CcSEcCtD
Cilazapril—Malaise—Prednisone—multiple sclerosis	0.000116	0.000859	CcSEcCtD
Cilazapril—Vertigo—Prednisone—multiple sclerosis	0.000115	0.000856	CcSEcCtD
Cilazapril—Syncope—Prednisone—multiple sclerosis	0.000115	0.000855	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—multiple sclerosis	0.000115	0.000853	CcSEcCtD
Cilazapril—Anorexia—Betamethasone—multiple sclerosis	0.000114	0.000851	CcSEcCtD
Cilazapril—Anorexia—Dexamethasone—multiple sclerosis	0.000114	0.000851	CcSEcCtD
Cilazapril—Urticaria—Prednisolone—multiple sclerosis	0.000114	0.00085	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—multiple sclerosis	0.000114	0.000849	CcSEcCtD
Cilazapril—Fatigue—Triamcinolone—multiple sclerosis	0.000114	0.000849	CcSEcCtD
Cilazapril—Fatigue—Methylprednisolone—multiple sclerosis	0.000114	0.000847	CcSEcCtD
Cilazapril—Pain—Triamcinolone—multiple sclerosis	0.000113	0.000842	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisone—multiple sclerosis	0.000113	0.000838	CcSEcCtD
Cilazapril—Hypotension—Dexamethasone—multiple sclerosis	0.000112	0.000835	CcSEcCtD
Cilazapril—Hypotension—Betamethasone—multiple sclerosis	0.000112	0.000835	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—multiple sclerosis	0.000112	0.00083	CcSEcCtD
Cilazapril—Vomiting—Mitoxantrone—multiple sclerosis	0.000111	0.000829	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—multiple sclerosis	0.000111	0.000826	CcSEcCtD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000111	0.0137	CbGpPWpGaD
Cilazapril—Hypertension—Prednisone—multiple sclerosis	0.000111	0.000823	CcSEcCtD
Cilazapril—Rash—Mitoxantrone—multiple sclerosis	0.000111	0.000823	CcSEcCtD
Cilazapril—Dermatitis—Mitoxantrone—multiple sclerosis	0.00011	0.000822	CcSEcCtD
Cilazapril—Chills—Methotrexate—multiple sclerosis	0.00011	0.000821	CcSEcCtD
Cilazapril—Headache—Mitoxantrone—multiple sclerosis	0.00011	0.000817	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000109	0.000814	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000109	0.000814	CcSEcCtD
Cilazapril—Myalgia—Prednisone—multiple sclerosis	0.000109	0.000811	CcSEcCtD
Cilazapril—Arthralgia—Prednisone—multiple sclerosis	0.000109	0.000811	CcSEcCtD
Cilazapril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000109	0.000811	CcSEcCtD
Cilazapril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000109	0.000809	CcSEcCtD
Cilazapril—Anxiety—Prednisone—multiple sclerosis	0.000109	0.000809	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—multiple sclerosis	0.000109	0.000808	CcSEcCtD
Cilazapril—Insomnia—Dexamethasone—multiple sclerosis	0.000109	0.000808	CcSEcCtD
Cilazapril—Insomnia—Betamethasone—multiple sclerosis	0.000109	0.000808	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000108	0.000806	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000108	0.000803	CcSEcCtD
Cilazapril—Paraesthesia—Betamethasone—multiple sclerosis	0.000108	0.000802	CcSEcCtD
Cilazapril—Paraesthesia—Dexamethasone—multiple sclerosis	0.000108	0.000802	CcSEcCtD
Cilazapril—Discomfort—Prednisone—multiple sclerosis	0.000108	0.000802	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000107	0.0133	CbGpPWpGaD
Cilazapril—Hypersensitivity—Prednisolone—multiple sclerosis	0.000106	0.000789	CcSEcCtD
Cilazapril—Dyspepsia—Dexamethasone—multiple sclerosis	0.000106	0.000786	CcSEcCtD
Cilazapril—Dyspepsia—Betamethasone—multiple sclerosis	0.000106	0.000786	CcSEcCtD
Cilazapril—Urticaria—Triamcinolone—multiple sclerosis	0.000105	0.000782	CcSEcCtD
Cilazapril—Urticaria—Methylprednisolone—multiple sclerosis	0.000105	0.00078	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—multiple sclerosis	0.000105	0.00078	CcSEcCtD
Cilazapril—Oedema—Prednisone—multiple sclerosis	0.000105	0.000778	CcSEcCtD
Cilazapril—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000104	0.000776	CcSEcCtD
Cilazapril—Decreased appetite—Betamethasone—multiple sclerosis	0.000104	0.000776	CcSEcCtD
Cilazapril—Decreased appetite—Dexamethasone—multiple sclerosis	0.000104	0.000776	CcSEcCtD
Cilazapril—Nausea—Mitoxantrone—multiple sclerosis	0.000104	0.000775	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000104	0.000771	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000104	0.000771	CcSEcCtD
Cilazapril—Fatigue—Dexamethasone—multiple sclerosis	0.000103	0.00077	CcSEcCtD
Cilazapril—Fatigue—Betamethasone—multiple sclerosis	0.000103	0.00077	CcSEcCtD
Cilazapril—Shock—Prednisone—multiple sclerosis	0.000103	0.000765	CcSEcCtD
Cilazapril—Pain—Betamethasone—multiple sclerosis	0.000103	0.000764	CcSEcCtD
Cilazapril—Pain—Dexamethasone—multiple sclerosis	0.000103	0.000764	CcSEcCtD
Cilazapril—Tachycardia—Prednisone—multiple sclerosis	0.000102	0.000759	CcSEcCtD
Cilazapril—Skin disorder—Prednisone—multiple sclerosis	0.000102	0.000755	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—multiple sclerosis	0.000101	0.000752	CcSEcCtD
Cilazapril—ACE—nerve—multiple sclerosis	0.0001	0.175	CbGeAlD
Cilazapril—Anorexia—Prednisone—multiple sclerosis	9.96e-05	0.000741	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—multiple sclerosis	9.93e-05	0.000739	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.92e-05	0.0123	CbGpPWpGaD
Cilazapril—Anaemia—Methotrexate—multiple sclerosis	9.89e-05	0.000736	CcSEcCtD
Cilazapril—Feeling abnormal—Betamethasone—multiple sclerosis	9.89e-05	0.000736	CcSEcCtD
Cilazapril—Feeling abnormal—Dexamethasone—multiple sclerosis	9.89e-05	0.000736	CcSEcCtD
Cilazapril—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.82e-05	0.00073	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.82e-05	0.00073	CcSEcCtD
Cilazapril—Hypersensitivity—Triamcinolone—multiple sclerosis	9.75e-05	0.000725	CcSEcCtD
Cilazapril—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.73e-05	0.000724	CcSEcCtD
Cilazapril—Malaise—Methotrexate—multiple sclerosis	9.65e-05	0.000718	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—multiple sclerosis	9.62e-05	0.000716	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—multiple sclerosis	9.58e-05	0.000713	CcSEcCtD
Cilazapril—Urticaria—Dexamethasone—multiple sclerosis	9.54e-05	0.000709	CcSEcCtD
Cilazapril—Urticaria—Betamethasone—multiple sclerosis	9.54e-05	0.000709	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.52e-05	0.000709	CcSEcCtD
Cilazapril—Dizziness—Prednisolone—multiple sclerosis	9.51e-05	0.000708	CcSEcCtD
Cilazapril—Asthenia—Triamcinolone—multiple sclerosis	9.49e-05	0.000706	CcSEcCtD
Cilazapril—Abdominal pain—Dexamethasone—multiple sclerosis	9.49e-05	0.000706	CcSEcCtD
Cilazapril—Abdominal pain—Betamethasone—multiple sclerosis	9.49e-05	0.000706	CcSEcCtD
Cilazapril—Asthenia—Methylprednisolone—multiple sclerosis	9.47e-05	0.000705	CcSEcCtD
Cilazapril—Insomnia—Prednisone—multiple sclerosis	9.46e-05	0.000703	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—multiple sclerosis	9.39e-05	0.000698	CcSEcCtD
Cilazapril—Pruritus—Triamcinolone—multiple sclerosis	9.36e-05	0.000696	CcSEcCtD
Cilazapril—Cough—Methotrexate—multiple sclerosis	9.34e-05	0.000695	CcSEcCtD
Cilazapril—Pruritus—Methylprednisolone—multiple sclerosis	9.34e-05	0.000695	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.2e-05	0.0114	CbGpPWpGaD
Cilazapril—Dyspepsia—Prednisone—multiple sclerosis	9.2e-05	0.000685	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—multiple sclerosis	9.11e-05	0.000678	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—multiple sclerosis	9.11e-05	0.000678	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—multiple sclerosis	9.11e-05	0.000678	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—multiple sclerosis	9.09e-05	0.000676	CcSEcCtD
Cilazapril—Rash—Prednisolone—multiple sclerosis	9.07e-05	0.000675	CcSEcCtD
Cilazapril—Dermatitis—Prednisolone—multiple sclerosis	9.06e-05	0.000674	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.05e-05	0.000673	CcSEcCtD
Cilazapril—Diarrhoea—Methylprednisolone—multiple sclerosis	9.03e-05	0.000672	CcSEcCtD
Cilazapril—Fatigue—Prednisone—multiple sclerosis	9.01e-05	0.000671	CcSEcCtD
Cilazapril—Headache—Prednisolone—multiple sclerosis	9.01e-05	0.000671	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—multiple sclerosis	9e-05	0.00067	CcSEcCtD
Cilazapril—Constipation—Prednisone—multiple sclerosis	8.94e-05	0.000665	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—multiple sclerosis	8.81e-05	0.000655	CcSEcCtD
Cilazapril—Dizziness—Triamcinolone—multiple sclerosis	8.75e-05	0.000651	CcSEcCtD
Cilazapril—Dizziness—Methylprednisolone—multiple sclerosis	8.73e-05	0.000649	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—multiple sclerosis	8.61e-05	0.000641	CcSEcCtD
Cilazapril—Asthenia—Betamethasone—multiple sclerosis	8.61e-05	0.000641	CcSEcCtD
Cilazapril—Asthenia—Dexamethasone—multiple sclerosis	8.61e-05	0.000641	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—multiple sclerosis	8.55e-05	0.000636	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—multiple sclerosis	8.55e-05	0.000636	CcSEcCtD
Cilazapril—Nausea—Prednisolone—multiple sclerosis	8.55e-05	0.000636	CcSEcCtD
Cilazapril—Pruritus—Betamethasone—multiple sclerosis	8.49e-05	0.000632	CcSEcCtD
Cilazapril—Pruritus—Dexamethasone—multiple sclerosis	8.49e-05	0.000632	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—multiple sclerosis	8.49e-05	0.000631	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—multiple sclerosis	8.45e-05	0.000628	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—C4A—multiple sclerosis	8.42e-05	0.0104	CbGpPWpGaD
Cilazapril—Vomiting—Triamcinolone—multiple sclerosis	8.41e-05	0.000626	CcSEcCtD
Cilazapril—Vomiting—Methylprednisolone—multiple sclerosis	8.39e-05	0.000624	CcSEcCtD
Cilazapril—Rash—Triamcinolone—multiple sclerosis	8.34e-05	0.000621	CcSEcCtD
Cilazapril—Dermatitis—Triamcinolone—multiple sclerosis	8.33e-05	0.00062	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—multiple sclerosis	8.33e-05	0.00062	CcSEcCtD
Cilazapril—Rash—Methylprednisolone—multiple sclerosis	8.32e-05	0.000619	CcSEcCtD
Cilazapril—Dermatitis—Methylprednisolone—multiple sclerosis	8.32e-05	0.000619	CcSEcCtD
Cilazapril—Urticaria—Prednisone—multiple sclerosis	8.3e-05	0.000618	CcSEcCtD
Cilazapril—Headache—Triamcinolone—multiple sclerosis	8.29e-05	0.000617	CcSEcCtD
Cilazapril—Headache—Methylprednisolone—multiple sclerosis	8.27e-05	0.000615	CcSEcCtD
Cilazapril—Abdominal pain—Prednisone—multiple sclerosis	8.26e-05	0.000615	CcSEcCtD
Cilazapril—Diarrhoea—Dexamethasone—multiple sclerosis	8.21e-05	0.000611	CcSEcCtD
Cilazapril—Diarrhoea—Betamethasone—multiple sclerosis	8.21e-05	0.000611	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—multiple sclerosis	8.16e-05	0.000607	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.96e-05	0.000592	CcSEcCtD
Cilazapril—Dizziness—Betamethasone—multiple sclerosis	7.94e-05	0.000591	CcSEcCtD
Cilazapril—Dizziness—Dexamethasone—multiple sclerosis	7.94e-05	0.000591	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—multiple sclerosis	7.9e-05	0.000588	CcSEcCtD
Cilazapril—Nausea—Triamcinolone—multiple sclerosis	7.86e-05	0.000585	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—multiple sclerosis	7.84e-05	0.000584	CcSEcCtD
Cilazapril—Nausea—Methylprednisolone—multiple sclerosis	7.84e-05	0.000583	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—multiple sclerosis	7.79e-05	0.000579	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—multiple sclerosis	7.77e-05	0.000578	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—multiple sclerosis	7.7e-05	0.000573	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—multiple sclerosis	7.69e-05	0.000572	CcSEcCtD
Cilazapril—Nateglinide—ALB—multiple sclerosis	7.66e-05	0.0105	CrCbGaD
Cilazapril—Vomiting—Dexamethasone—multiple sclerosis	7.63e-05	0.000568	CcSEcCtD
Cilazapril—Vomiting—Betamethasone—multiple sclerosis	7.63e-05	0.000568	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—multiple sclerosis	7.59e-05	0.000565	CcSEcCtD
Cilazapril—Rash—Dexamethasone—multiple sclerosis	7.57e-05	0.000563	CcSEcCtD
Cilazapril—Rash—Betamethasone—multiple sclerosis	7.57e-05	0.000563	CcSEcCtD
Cilazapril—Dermatitis—Dexamethasone—multiple sclerosis	7.56e-05	0.000563	CcSEcCtD
Cilazapril—Dermatitis—Betamethasone—multiple sclerosis	7.56e-05	0.000563	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.54e-05	0.000561	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—multiple sclerosis	7.53e-05	0.00056	CcSEcCtD
Cilazapril—Headache—Dexamethasone—multiple sclerosis	7.52e-05	0.000559	CcSEcCtD
Cilazapril—Headache—Betamethasone—multiple sclerosis	7.52e-05	0.000559	CcSEcCtD
Cilazapril—Asthenia—Prednisone—multiple sclerosis	7.5e-05	0.000558	CcSEcCtD
Cilazapril—Pain—Methotrexate—multiple sclerosis	7.47e-05	0.000556	CcSEcCtD
Cilazapril—Pruritus—Prednisone—multiple sclerosis	7.4e-05	0.00055	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	7.34e-05	0.00909	CbGpPWpGaD
Cilazapril—Feeling abnormal—Methotrexate—multiple sclerosis	7.2e-05	0.000536	CcSEcCtD
Cilazapril—Diarrhoea—Prednisone—multiple sclerosis	7.15e-05	0.000532	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.14e-05	0.000532	CcSEcCtD
Cilazapril—Nausea—Dexamethasone—multiple sclerosis	7.13e-05	0.00053	CcSEcCtD
Cilazapril—Nausea—Betamethasone—multiple sclerosis	7.13e-05	0.00053	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—multiple sclerosis	6.94e-05	0.000516	CcSEcCtD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.93e-05	0.00858	CbGpPWpGaD
Cilazapril—Dizziness—Prednisone—multiple sclerosis	6.91e-05	0.000514	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—multiple sclerosis	6.91e-05	0.000514	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	6.86e-05	0.0085	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	6.86e-05	0.0085	CbGpPWpGaD
Cilazapril—Vomiting—Prednisone—multiple sclerosis	6.65e-05	0.000495	CcSEcCtD
Cilazapril—Rash—Prednisone—multiple sclerosis	6.59e-05	0.00049	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—multiple sclerosis	6.59e-05	0.00049	CcSEcCtD
Cilazapril—Headache—Prednisone—multiple sclerosis	6.55e-05	0.000487	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—multiple sclerosis	6.44e-05	0.000479	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.43e-05	0.00796	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	6.36e-05	0.00787	CbGpPWpGaD
Cilazapril—Asthenia—Methotrexate—multiple sclerosis	6.27e-05	0.000466	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	6.24e-05	0.00773	CbGpPWpGaD
Cilazapril—Nausea—Prednisone—multiple sclerosis	6.21e-05	0.000462	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—multiple sclerosis	6.18e-05	0.00046	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.17e-05	0.00764	CbGpPWpGaD
Cilazapril—Diarrhoea—Methotrexate—multiple sclerosis	5.98e-05	0.000445	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	5.93e-05	0.00735	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	5.89e-05	0.00729	CbGpPWpGaD
Cilazapril—Dizziness—Methotrexate—multiple sclerosis	5.78e-05	0.00043	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—multiple sclerosis	5.55e-05	0.000413	CcSEcCtD
Cilazapril—Rash—Methotrexate—multiple sclerosis	5.51e-05	0.00041	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—multiple sclerosis	5.5e-05	0.000409	CcSEcCtD
Cilazapril—Headache—Methotrexate—multiple sclerosis	5.47e-05	0.000407	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	5.35e-05	0.00663	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	5.35e-05	0.00662	CbGpPWpGaD
Cilazapril—Nausea—Methotrexate—multiple sclerosis	5.19e-05	0.000386	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.04e-05	0.00624	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.68e-05	0.00579	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	4.64e-05	0.00574	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD28—multiple sclerosis	4.5e-05	0.00557	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	4.31e-05	0.00533	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	4.27e-05	0.00529	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40—multiple sclerosis	4.11e-05	0.00509	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	4.05e-05	0.00502	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.98e-05	0.00493	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	3.92e-05	0.00485	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.7e-05	0.00458	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.7e-05	0.00458	CbGpPWpGaD
Cilazapril—SLC15A2—retina—multiple sclerosis	3.62e-05	0.0633	CbGeAlD
Cilazapril—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	3.57e-05	0.00442	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.52e-05	0.00436	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.34e-05	0.00413	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.27e-05	0.00405	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3.21e-05	0.00398	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—multiple sclerosis	3.15e-05	0.0039	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	3.15e-05	0.0039	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL4—multiple sclerosis	3.06e-05	0.00379	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	3e-05	0.00371	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.82e-05	0.0035	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.81e-05	0.00348	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.78e-05	0.00344	CbGpPWpGaD
Cilazapril—ACE—spinal cord—multiple sclerosis	2.68e-05	0.0468	CbGeAlD
Cilazapril—SLC15A2—medulla oblongata—multiple sclerosis	2.62e-05	0.0457	CbGeAlD
Cilazapril—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.54e-05	0.00314	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.5e-05	0.00309	CbGpPWpGaD
Cilazapril—SLC15A2—midbrain—multiple sclerosis	2.39e-05	0.0418	CbGeAlD
Cilazapril—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.34e-05	0.0029	CbGpPWpGaD
Cilazapril—SLC15A2—spinal cord—multiple sclerosis	2.34e-05	0.0408	CbGeAlD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.32e-05	0.00287	CbGpPWpGaD
Cilazapril—ACE—nervous system—multiple sclerosis	2.26e-05	0.0394	CbGeAlD
Cilazapril—ACE—central nervous system—multiple sclerosis	2.17e-05	0.0379	CbGeAlD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.09e-05	0.00258	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.03e-05	0.00251	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—POMC—multiple sclerosis	2.02e-05	0.00251	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	1.98e-05	0.00245	CbGpPWpGaD
Cilazapril—SLC15A2—nervous system—multiple sclerosis	1.97e-05	0.0344	CbGeAlD
Cilazapril—SLC15A2—central nervous system—multiple sclerosis	1.9e-05	0.0331	CbGeAlD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.89e-05	0.00234	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.85e-05	0.00229	CbGpPWpGaD
Cilazapril—SLC15A2—cerebellum—multiple sclerosis	1.85e-05	0.0323	CbGeAlD
Cilazapril—ACE—brain—multiple sclerosis	1.73e-05	0.0301	CbGeAlD
Cilazapril—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.65e-05	0.00205	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.65e-05	0.00204	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.63e-05	0.00202	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.58e-05	0.00196	CbGpPWpGaD
Cilazapril—SLC15A2—brain—multiple sclerosis	1.5e-05	0.0263	CbGeAlD
Cilazapril—ABCB1—retina—multiple sclerosis	1.46e-05	0.0255	CbGeAlD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.39e-05	0.00173	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SRM—multiple sclerosis	1.29e-05	0.0016	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.28e-05	0.00159	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.27e-05	0.00157	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.25e-05	0.00155	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.2e-05	0.00148	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.18e-05	0.00146	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.1e-05	0.00137	CbGpPWpGaD
Cilazapril—ABCB1—medulla oblongata—multiple sclerosis	1.06e-05	0.0185	CbGeAlD
Cilazapril—ABCB1—midbrain—multiple sclerosis	9.67e-06	0.0169	CbGeAlD
Cilazapril—ABCB1—spinal cord—multiple sclerosis	9.43e-06	0.0165	CbGeAlD
Cilazapril—ABCB1—Metabolism—CYP24A1—multiple sclerosis	9.09e-06	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP27B1—multiple sclerosis	9.09e-06	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPC5—multiple sclerosis	8.31e-06	0.00103	CbGpPWpGaD
Cilazapril—ABCB1—nervous system—multiple sclerosis	7.95e-06	0.0139	CbGeAlD
Cilazapril—ABCB1—central nervous system—multiple sclerosis	7.65e-06	0.0134	CbGeAlD
Cilazapril—ABCB1—cerebellum—multiple sclerosis	7.48e-06	0.0131	CbGeAlD
Cilazapril—ABCB1—Metabolism—RRM1—multiple sclerosis	6.89e-06	0.000852	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.35e-06	0.000786	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.34e-06	0.000785	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.21e-06	0.000769	CbGpPWpGaD
Cilazapril—ABCB1—brain—multiple sclerosis	6.07e-06	0.0106	CbGeAlD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.92e-06	0.000733	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.98e-06	0.000493	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BCHE—multiple sclerosis	3.95e-06	0.00049	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOE—multiple sclerosis	2.38e-06	0.000295	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—POMC—multiple sclerosis	2.04e-06	0.000253	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—multiple sclerosis	1.86e-06	0.000231	CbGpPWpGaD
